Hypersensitivity with sirolimus and paclitaxel drug-eluting stents

By  

Inpharma, Vol. 1, Iss. 1524, 2006-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Update on Sirolimus Drug-Eluting Stents

By  

Current Pharmaceutical Design, Vol. 10, Iss. 4, 2004-02 ,pp. : 337-348

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Eluting Stents: Friend or Foe? A Review of Cellular Mechanisms Behind the Effects of Paclitaxel and Sirolimus Eluting Stents

By  

Current Drug Metabolism, Vol. 9, Iss. 6, 2008-07 ,pp. : 554-566

Bentham Science Publishers

Access to resources Recommend Favorite

Sirolimus- or paclitaxel-eluting stents for coronary artery revascularisation

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 2, 2006-02 ,pp. : 225-228

Informa Healthcare

Access to resources Recommend Favorite

Early Systemic Inflammatory Response to Drug-Eluting Stents Implantation: The Heart of the Difference?: Editorial to: “Comparison of Changes in Early Inflammatory Markers Between Sirolimus- and Paclitaxel-Eluting Stent Implantation” by Li et al.

By Pires Nuno   Jukema J.  

Cardiovascular Drugs and Therapy, Vol. 23, Iss. 2, 2009-04 ,pp. : 103-105

Springer Publishing Company

Access to resources Recommend Favorite